BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
580
Frequently Asked Questions
What is Market Cap of Biocryst Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Biocryst Pharmaceuticals Inc. market cap is $1.74B.
What is the 52-week high for Biocryst Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biocryst Pharmaceuticals Inc. 52 week high is $11.31 as of September 07, 2025.
What is the 52-week low for Biocryst Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biocryst Pharmaceuticals Inc. 52 week low is $6.02 as of September 07, 2025.
What is Biocryst Pharmaceuticals Inc. stock price today?
Biocryst Pharmaceuticals Inc. stock price today is $8.27.
What was Biocryst Pharmaceuticals Inc. stock price yesterday?
Biocryst Pharmaceuticals Inc. stock price yesterday was $8.27.
What is the PE ratio of Biocryst Pharmaceuticals Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Biocryst Pharmaceuticals Inc.’s P/E ratio is -47.58.
What is the Price-to-Book ratio of Biocryst Pharmaceuticals Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Biocryst Pharmaceuticals Inc. P/B ratio is -4.1175.
What is the 50-day moving average of Biocryst Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Biocryst Pharmaceuticals Inc. 50-day moving average is $8.56.
How many employess does Biocryst Pharmaceuticals Inc. has?
BCRX Biocryst Pharmaceuticals Inc.